Sign in

CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
301341024
Phone
(631) 760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
  1. 4 Open-market buy 10% owner bought 1,300 shares at $3.92 ($5,097)
  2. 4 Grant or award VP of Research and Development acquired 263 shares (grant or award)
  3. 4 Open-market buy President, CEO, COB bought 500 shares at $3.91 ($1,956)
  4. 4 Open-market buy President, CEO, COB bought 200 shares at an average $3.95 ($790)
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. 4 Open-market buy 10% owner bought 1,600 shares at an average $4.25 ($6,806)
  7. 4 Open-market buy 10% owner bought 6,000 shares at an average $4.57 ($27,398)
  8. 4 Open-market buy President, CEO, COB bought 100 shares at $4.28 ($428)
  9. 4 Grant or award VP of Research and Development acquired 565 shares (grant or award)
  10. 4 Open-market buy 10% owner bought 4,200 shares at an average $4.92 ($20,677)
  11. 4 Open-market buy Chief Financial Officer bought 200 shares at $4.56 ($912)
  12. 4 Open-market buy 10% owner bought 1,000 shares at $4.69 ($4,688)
  13. 4 Open-market buy 10% owner bought 9,213 shares at $4.46 ($41,122)
  14. 4 Open-market buy President, CEO, COB bought 200 shares at $4.60 ($920)
  15. 4 Open-market buy 10% owner bought 10,957 shares at $3.61 ($39,592)
  16. 4 Open-market buy 10% owner bought 4,950 shares at $3.51 ($17,364)
  17. 4 Open-market buy President, CEO, COB bought 2,700 shares at $3.52 ($9,494)
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. 10-Q Report Quarterly Report

Page 12 of 38 · 755 filings